Ras oncogene expression as a prognostic indicator in rectal adenocarcinoma
- 1 July 1988
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 45 (1) , 15-20
- https://doi.org/10.1016/0022-4804(88)90015-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Ras Oncogene p21 Levels Parallel Malignant Potential of Different Human Colonic Benign ConditionsArchives of Surgery, 1987
- Immunohistochemical staining of colorectal tissues with monoclonal antibodies to ras oncogene p21 product and carbohydrate determinant antigen 19-9.Journal of Clinical Pathology, 1987
- Immunohistochemical detection of ras oncogene p21 product in benign and malignant mammary tissue in man.Journal of Clinical Pathology, 1986
- The relation of ras family oncogene expression to conventional staging criteria and clinical outcome in colorectal carcinomaBritish Journal of Cancer, 1986
- Immunocytochemical demonstration of p21 ras family oncogene product in normal mucosa and in premalignant and malignant tumours of the colorectumBritish Journal of Cancer, 1985
- NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice.Molecular and Cellular Biology, 1985
- Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseasesNature, 1984
- Elevated expression of the human ras oncogene family in premalignant and malignant tumours of the colorectumBritish Journal of Cancer, 1984
- Expression of Cellular Oncogenes in Human MalignanciesScience, 1984
- THE PROGNOSTIC SIGNIFICANCE OF DIRECT EXTENSION OF CARCINOMA OF THE COLON AND RECTUMAnnals of Surgery, 1954